Orange Book product
SUMATRIPTAN SUCCINATE EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML)
Orange Book ANDA 078318 · TEVA PARENTERAL MEDICINES INC · Discontinued
Key facts
| Proprietary name | SUMATRIPTAN SUCCINATE |
|---|---|
| Active ingredients | SUMATRIPTAN SUCCINATE |
| Strength | EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML) |
| Dosage form | INJECTABLE |
| Route | SUBCUTANEOUS |
| Application | ANDA078318 |
| Applicant holder | TEVA PARENTERAL MEDICINES INC |
| Marketing status | Discontinued |
| Reference listed drug (RLD) | No |
| Reference standard (RS) | No |
| Approval date | Feb 6, 2009 |
At a glance
- 1–9 Marketed products with the same ingredient, strength and form
- 1–9 Products in this application
- No Reference listed drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Orange Book products
The FDA Orange Book lists approved drug products with their therapeutic equivalence (TE) codes, reference listed drugs and marketing status. Products approved before 1982 show an approval date of Jan 1, 1982.